4.8 Review

Genome-wide mechanisms of Smad binding

Journal

ONCOGENE
Volume 32, Issue 13, Pages 1609-1615

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/onc.2012.191

Keywords

ChIP-chip; ChIP-sequencing; TGF-beta; BMP; Smad

Funding

  1. Swedish Cancer Society [100452]
  2. KAKENHI [22112002, 22790750]
  3. Global Center of Excellence Program (Integrative Life Science Based on the Study of Biosignaling Mechanisms) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan
  4. Takeda Science Foundation
  5. Ministry of Health, Labour and Welfare of Japan [H22-013]
  6. Grants-in-Aid for Scientific Research [22112001, 22790750, 24390070, 22112002] Funding Source: KAKEN

Ask authors/readers for more resources

A dual role of transforming growth factor beta (TGF-beta), to both suppress and promote tumor progression and metastasis, has been well established, but its molecular basis has remained elusive. In this review, we focus on Smad proteins, which are central mediators of the signal transduction of TGF-beta family members. We describe current knowledge of cell-type-specific binding patterns of Smad proteins and mechanisms of transcriptional regulation, obtained from recent studies on genome-wide binding sites of Smad molecules. We also discuss potential application of the genome-wide analyses for cancer research, which will allow clarification of the complex mechanisms occurring during cancer progression, and the identification of potential biomarkers for future cancer diagnosis, prognosis and therapy. Oncogene (2013) 32, 1609-1615; doi:10.1038/onc.2012.191; published online 21 May 2012

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available